Par Drugs and Chemicals Limited (NSE:PAR)

Market Cap	1.25B +2.4%
Revenue (ttm)	1.09B +4.3%
Net Income	144.93M +2.4%
EPS	11.78 +2.4%
Shares Out	12.30M
PE Ratio	8.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,514
Open	100.60
Previous Close	102.48
Day's Range	100.10 - 103.65
52-Week Range	78.05 - 122.43
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 8, 2026

About Par Drugs and Chemicals

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 121
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PAR

Financial Performance

In fiscal year 2026, Par Drugs and Chemicals's revenue was 1.04 billion, an increase of 2.66% compared to the previous year's 1.01 billion. Earnings were 131.09 million, a decrease of -1.87%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error